Zhao Xiangguo, Tao Xinyi, Wei Dongzhi, Song Qingxun
State Key Laboratory of Bioreactor Engineering, Institute of Biochemistry, East China University of Science and Technology, Shanghai, China.
Eur J Med Chem. 2006 Nov;41(11):1352-8. doi: 10.1016/j.ejmech.2006.05.014. Epub 2006 Jun 27.
Novel ester prodrugs (II, III and IV) of ibuprofen (I) were synthesized using alpha-methyl, ethyl and propyl glucopyranoside as promoieties and tested for their anti-inflammatory, analgesic and ulcerogenic activities. Study of their chemical hydrolysis in aqueous buffer (pH 3.0-10.0) showed that these compounds acted as true prodrugs of ibuprofen, giving the ibuprofen and alkyl glucopyranoside. Additionally, all the derivatives studied did cleave rapidly inside the biological system and on oral administration did elicit a pharmacological profile quite similar to that of ibuprofen, but, unlike this drug, they displayed reduced gastric ulceration. In conclusion, these alkyl glucopyranoside esters have promising properties as prodrugs for oral delivery of ibuprofen.
以α-甲基、乙基和丙基吡喃葡萄糖苷作为前体基团合成了布洛芬(I)的新型酯前药(II、III和IV),并对其抗炎、镇痛和致溃疡活性进行了测试。在水性缓冲液(pH 3.0 - 10.0)中对其化学水解的研究表明,这些化合物作为布洛芬的真正前药,生成了布洛芬和烷基吡喃葡萄糖苷。此外,所研究的所有衍生物在生物系统内均能迅速裂解,口服给药时引发的药理学特征与布洛芬相当相似,但与该药物不同的是,它们的胃溃疡形成减少。总之,这些烷基吡喃葡萄糖苷酯作为布洛芬口服给药的前药具有良好的性能。